What Is Kratom and Why Are People Talking About It?

A few years back, kratom barely registered outside specialist circles. Now it shows up in pharmacy aisles, on Reddit threads about quitting alcohol, in harm reduction conversations, and increasingly in European expat communities curious about what Americans keep arguing about.

The arguments, for the record, go in every direction. Passionate advocates. Concerned regulators. Researchers still catching up. Understanding what the plant actually is cuts through a lot of noise.

Old Plant, New Audience

Mitragyna speciosa – the tree behind the name – has been growing across Indonesia, Thailand, and Malaysia for as long as anyone has kept records. It’s in the coffee family. The leaves were chewed or brewed into rough teas by agricultural workers managing long physical days in the heat. Nobody was studying it. Nobody needed to. It was just part of the local toolkit, the same way coca leaves function in parts of South America or betel nut across Southeast Asia.

Western markets discovered it somewhere around the 2010s. American online communities latched on first, mostly people managing pain or looking for ways to reduce alcohol and opioid use. From there, it spread into general wellness retail, and the conversation hasn’t stopped since.

The Chemistry That Makes It Complicated

Two compounds – mitragynine and 7-hydroxymitragynine – sit at the centre of everything. Both bind to opioid receptors. Not cannabinoid receptors, not serotonin pathways. Opioid receptors. Morphine uses the same sites. So does codeine. That single fact is why kratom generates a different kind of attention than, say, ashwagandha.

Here’s what makes it genuinely unusual, though. Low doses pull in one direction – energy, mood, focus, something closer to a strong coffee than anything sedating. Push past that threshold and the whole character shifts: body relaxation, pain blunting, a heaviness that has nothing in common with the small-dose experience. The plant doesn’t just scale. It pivots. People who try it expecting a linear dose-response get caught out badly.

Dependency is real and worth stating plainly. Not in the same territory as pharmaceutical opioids, but consistent daily use at higher doses builds tolerance and stopping abruptly can involve several unpleasant days. That’s different from most of what sits on the botanical supplement shelf.

Why the Timing Worked

The opioid crisis in the US created an enormous pool of people looking for alternatives – for managing pain without prescriptions, for stepping down from stronger substances, for something that engaged those receptor systems without carrying the same risk profile. Kratom fit that gap imperfectly but usably, and word spread fast through communities where pharmaceutical options had already failed people.

Simultaneously, the broader sober-curious and botanical wellness movements were growing. Among people now reaching for concentrated kratom tinctures and other formats, the appeal overlaps with what draws people to kava or CBD – plant-sourced, tangible, a deliberate alternative to alcohol or pharmaceuticals. Kratom delivers a more pronounced effect than most of its shelf-neighbours, which cuts both ways depending on who’s using it and how.

Retail access expanded considerably once distribution networks that grew around hemp products started carrying kratom alongside them. Moving from specialist shops to mainstream channels brought it to audiences who’d never have encountered it otherwise.

Where It’s Legal – and Where It Isn’t

This is the part that changes fastest and matters most practically.

In the US, federal law doesn’t prohibit kratom, but states have moved independently. Alabama, Arkansas, Indiana, Wisconsin, Vermont, Louisiana, Connecticut, Michigan, and Kansas had banned it outright by mid-2026. Tennessee was close behind. The map keeps shifting and has moved more toward restriction than liberalisation over the past two years.

Europe is its own puzzle. Britain’s Psychoactive Substances Act 2016 doesn’t name kratom specifically but creates a grey zone that affects import and sale. Germany, Sweden, and several other European countries have made explicit prohibitions. Spain has no current ban, which matters for EWN readers – but “currently legal” in any botanical category is worth verifying before purchasing because these classifications move without much public notice.

Worth flagging for expats: Legal status in your home country is irrelevant to what applies where you live or travel. Spain’s current position doesn’t tell you anything about Germany or the UK. Always check locally.

The Formats People Use

Ground leaf powder is the starting point – mixed into juice or water, bitter enough that most people grimace the first time. Capsules do the same job without the taste problem and make dosing more measurable. Tinctures and liquid extracts strip things down to concentrated alkaloid content: smaller volumes, faster onset, considerably higher potency per millilitre than powder. That concentration is useful for experienced users who know their tolerance. For anyone new to kratom, starting with powder or capsules gives more room to calibrate before the ceiling rises.

What Science Has and Hasn’t Established

The receptor mechanisms are documented and reasonably well understood. Alkaloid profiles can be measured and tested. What doesn’t exist yet – despite millions of regular users – is large-scale clinical trial data on long-term use, optimal dosing, or therapeutic applications.

The FDA has raised concerns about liver toxicity, particularly linked to high-potency extract products, and about dependency risk across all formats. Traditional use spans centuries in Southeast Asia without the population-level catastrophe that critics sometimes predict, but traditional use also looked nothing like daily high-dose extract consumption.

Third-party lab testing from a vendor is the minimum bar worth setting before purchasing anything. It confirms alkaloid content and checks for contaminants – two variables that matter considerably more with kratom than with most supplements, precisely because the potency is real and the quality varies enormously across the unregulated market.